Vasorelaxant effects of icariin on isolated canine coronary artery

Journal of Cardiovascular Pharmacology

Volumn 49, Issue 4, 2007, Pages 207-213

  Xu, Hai Bin ^a   Huang, Zhao Quan ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Canine coronary artery; Icariin; NO dependent; Vasorelaxation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; ICARIIN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; TETRYLAMMONIUM; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DOG; DRUG EFFECT; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; ISOLATION PROCEDURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VASODILATATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CORONARY VESSELS; DINOPROST; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; GLYBURIDE; INDOMETHACIN; MALE; MODELS, ANIMAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; OXADIAZOLES; OXYTOCICS; POTASSIUM CHANNEL BLOCKERS; QUINOXALINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAETHYLAMMONIUM; VASODILATION;

EID: 34247190773     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3180325abe     Document Type: Article

References (34)

1. Zeiher AM, Drexler H, Wollschlager H, et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
2. Bell DM, Johna TE, Loupz FM. Endothelial dysfunction: implications for therapy of cardiovascular diseases. Ann Pharmcother. 1998;32:459-470.
3. He W, Sun H, Yang B, et al. Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung. 1995;45:910-913.
4. Zhang YW, Morita I, Zhao G, et al. Screening of Anti-hypoxia/ reoxygenation agents by an in vitro model: Part 1. Natural inhibitors for protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells. Planta Med. 2000;66:114-118.
5. Qiao L, Xin ZC, Fu J, et al. Expression of phosphodiesterase 5 in clitoris cavernosum and effect of icariin on cGMP levels in vitro. Chin J Urol. 2002;23:670-672.
6. Yin XX, Chen ZQ, Dang GT, et al. Effects of Epimedium pubescens icariin on proliferation and differentiation of human osteoblasts. Zhongguo Zhong Yao Za Zhi. 2005;30:289-291.
7. Ji RR, Li FY, Zhang XJ. Effect of icariin on hypoxia induced vascular endothelial cells injury. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005;25:525-530.
8. Zhu DY, Qu LH, Zhang XN, et al. Icariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells. Eur J Pharmacol. 2005;514:99-110.
9. 2 in vitro. Pharmacol Res. 2005;52:174-182.
10. Ling HY, Lou YJ, Lou HG, et al. Protective effect of total flavones from Elsholtzia blanda (TFEB) on myocardial ischemia induced by coronary occlusion in canines. J Ethnopharmacol. 2004;94,101-107.
11. Chan EC, Pannangpetch P, Woodman OL. Relaxation of flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships. J Cardiovasc Pharmacol. 2000;35:326-333.
12. Rees DD, Palmer RM, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
13. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Clin Exp Pharmacol Physiol. 1996;23:1082-1090.
14. Chan ECH, Pannangpetch P, Woodman OL. Relaxation of flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships. J Cardiovasc Pharmacol. 2000;35:326-333.
15. Ajay M, Gilani AU, Mustafa MR. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci. 2003;74:603-612.
16. Woodman OL, Meeker WF, Boujaoude M. Vasorelaxant and antioxidant activity of flavonols and flavones: structure-activity relationships. J Cardiovasc Pharmacol. 2005;46:302-309.
17. Xin ZC, Kim EK, Tian ZJ, et al. Icariin on the relaxation effect of copurs cavenosm smooth muscle. Chin Sci Bull. 2001;46:1186-1190.
18. Jiang ZJ, Hu BR, Fu Q, et al. Relaxant effects of icariin on the rabbit copurs cavenosm and its mechanism. J Huazhong Univ Sci Tech (Health Sci). 2004;33:679-682.
19. i during inhibition of coronary smooth muscle contraction by 17-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther. 1999;291:44-52.
20. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;396:269-272.
21. 2+ channel in cardiac excitation-contraction coupling in the rat: evidence from Ca2+ transients and contraction. J Physiol. 1991;432:283-312.
22. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597-601.
23. Anter E, Thomas SR, Schulz E, et al. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem. 2004;279:46637-46643.
24. Lorenz M, Wessler S, Follmann E, et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vaso-relaxation. J Biol Chem. 2004;279:6190-6195.
25. Xu JW, Ikeda K, Yamori Y. Upregulation of endothelial nitric oxide synthase by cyanidin-3-glucoside, a typical anthocyanin pigment. Hypertension. 2004;44:217-222.
26. Michell BJ, Griffiths JE, Mitchelhill KI, et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol. 1999;9:845-848.
27. Wang W, Wang S, Nishanian EV, et al. Signaling by eNOS through a superoxide-dependent p42/44 mitogen-activated protein kinase pathway. Am J Physiol Cell Physiol. 2001;281:544-554.
28. Liu J, Lou YJ. Determination of icariin and metabolites in rat serum by capillary zone electrophoresis: rat pharmacokinetic studies after administration of icariin. J Pharm Biomed Anal. 2004;36:365-370.
29. Wang ZQ, Lou YJ. Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. Eur J Pharmacol. 2004;504:147-153.
30. Lima SM, Aldrighi JM, Consolim-Colombo FM, et al. Acute administration of 17beta-estradiol improves endothelium-dependent vasodilation in postmenopausal women. Maturitas. 2005;50:266-274.
31. Klinge CM, Blankenship KA, Risinger KE, et al. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem. 2005;280:7460-7468.
32. Al Zubair K, Razak A, Bexis S, et al. Relaxations to oestrogen receptor subtype selective agonists in rat and mouse arteries. Eur J Pharmacol. 2005;513:101-108.
33. Prasad S, Wilkinson J, Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Engl J Med. 2000;343:1342.
34. Xin ZC, Kim EK, Lin CS, et al. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J Androl. 2003;5:15-18.